Details for New Drug Application (NDA): 022283
✉ Email this page to a colleague
The generic ingredient in ZEGERID OTC is omeprazole; sodium bicarbonate. There are one hundred and thirty-one drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the omeprazole; sodium bicarbonate profile page.
Summary for 022283
Tradename: | ZEGERID OTC |
Applicant: | Riley Consumer |
Ingredient: | omeprazole; sodium bicarbonate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | FOR SUSPENSION;ORAL | Strength | 20MG/PACKET;1.68GM/PACKET | ||||
Approval Date: | Jun 17, 2013 | TE: | RLD: | Yes |
Expired US Patents for NDA 022283
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Riley Consumer | ZEGERID OTC | omeprazole; sodium bicarbonate | FOR SUSPENSION;ORAL | 022283-001 | Jun 17, 2013 | ⤷ Sign Up | ⤷ Sign Up |
Riley Consumer | ZEGERID OTC | omeprazole; sodium bicarbonate | FOR SUSPENSION;ORAL | 022283-001 | Jun 17, 2013 | ⤷ Sign Up | ⤷ Sign Up |
Riley Consumer | ZEGERID OTC | omeprazole; sodium bicarbonate | FOR SUSPENSION;ORAL | 022283-001 | Jun 17, 2013 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription